An attempt by the British Generic Manufacturers Association (BGMA) to get a seat at the negotiation table for the new Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) has been knocked ...
Ahead of his speaking engagement at the Generics &amp, Biosimilars summit 2012, Deepak shares his insights into the current state of the generics industry and how he thinks it will evolve in the ...